Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2

Clin Infect Dis. 2021 Nov 16;73(10):1945-1946. doi: 10.1093/cid/ciab129.

Authors

Noémie Zucman^{1

2}, Fabrice Uhel¹, Diane Descamps^{2

3

4}, Damien Roux^{1

2

4}, Jean-Damien Ricard^{1

2

4}

Affiliations

¹ AP-HP, Hôpital Louis Mourier, Médecine Intensive Réanimation, DMU ESPRIT, Colombes, France.
² Université de Paris, UFR de médecine Paris Nord, Paris, France.
³ AP-HP, Hôpital Bichat Claude Bernard, Virologie, Paris, France.
⁴ IAME, INSERM UMR 1137, Paris, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19*
Humans
Reinfection
SARS-CoV-2*

Substances

Antibodies, Viral